Outsourcing has been called ‘one of the greatest organisational and industry structure shifts of the century’. This shift has been
particularly marked within the pharmaceutical sector, with pharmaceutical and biotechnology companies now outsourcing at
almost every stage of the value chain. This in turn has resulted in a sector with an estimated value of US$5 billion and a
growth rate to 2005 of 20%.
Pharmaceutical companies are now supporting a thriving services sectorby outsourcing a broad range of skills and
technologies required for drug discovery, development and manufacturing.
Key drivers include:
Increased focus on ‘core competencies’
Increase in the range of services and functions available for outsourcing
Growth of smaller biotechnology companies
Pressure to reduce time to market
Transparency of costs offered by outsourcing companies
Specialisation, with outsourcing companies able to make constant and intensive use of their capital
Globalisation of the pharmaceutical industry
Pharmaceutical Outsourcing Decisions is designed around relevant and focused editorial with the purpose of engaging key
decision-makers. Stimulating and provocative articles will encourage action among readers looking to align with organisations
that will enable them to fulfil their strategic objectives.